FundedIQ

Recently Funded Series E Biotechnology Startups

Updated Aug 2026

There are 26 funded Series E Biotechnology startups in the FundedIQ database, each with its funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Series E Biotechnology startup funding landscape, along with the 26 most recently funded Series E Biotechnology startups.

Berkeley and Boston hold the deepest concentrations of these companies. Series E Biotechnology startups closed 8 funding rounds over the last 24 months, 4 of them in the last 12 months, and raised $527M in disclosed capital. The median disclosed round is $57M, with the middle half of rounds falling between $41M and $80M.

These biotechnology firms are mature organizations centered in Berkeley and Boston. Their scale suggests a shift from research toward commercial operations. Large headcounts indicate established infrastructure, making these companies targets for enterprise software or high-end lab equipment. The concentration in the United States reflects a preference for domestic regulatory proximity.

Series E Biotechnology funded startup statistics

Funded Series E Biotechnology startups
26
tracked in the database
Funding rounds, last 12 months
4
8 over 24 months
Disclosed capital raised, 24 months
$527M
7 of 8 rounds disclosed an amount
Median round size
$57M
middle half $41M to $80M

Most recent funding round on record: Aug 2026.

26 most recently funded Series E Biotechnology startups

26 shown

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

L
Cambridge, United States · Biotechnology
LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of…
Series E ·
$188M
E
San Diego, United States · Biotechnology
Element Biosciences is a biotech company specializing in creating new genetic analysis tools. They are…
Series E ·
Undisclosed
G
Tempe, United States · Biotechnology
GT Medical Technologies is a medical technology company focused on improving outcomes for patients with brain…
Series E ·
$100M
A
Lexington, United States · Biotechnology
Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and…
Series E ·
$40M
S
Holland, United States · Biotechnology
Shoulder Innovations is a medical device company that has developed inset glenoid fixation technology,…
Series E ·
$40M
B
Boston, United States · Biotechnology
Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet.…
Series E ·
$60M
T
Westfield, United States · Biotechnology
Clinical-stage biotechnology company dedicated to discovery and development of therapeutics in infectious…
Series E ·
$42M
I
Burlingame, United States · Biotechnology
Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by 'reading' the…
Series E ·
$57M
A
Lexington, United States · Biotechnology
Alzheon is a biotechnology company that specializes in brain health, memory, and aging in women and children.…
Series E ·
$100M
N
San Francisco, United States · Biotechnology
Neurona Therapeutics is a biotechnology company in the pre-clinical stage, founded by four neuroscientists…
Series E ·
$120M
P
Berkeley, United States · Biotechnology
Perfect Day is a groundbreaking company that creates dairy proteins with the same nutritional value as cow's…
Series E ·
$90M
L
Watertown, United States · Biotechnology
Lyndra Therapeutics specializes in creating oral medications that provide prolonged drug release. Their focus…
Series E ·
$101M
N
Pittsburgh, United States · Biotechnology
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
Series E ·
$21M
E
Albany, United States · Biotechnology
Eben Bayer and Gavin McIntyre are fascinated by mushrooms growing on wood chips and observing how the fungal…
Series E ·
$30M
C
Berkeley, United States · Biotechnology
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases. They employ…
Series E ·
$150M
A
Del Mar, United States · Biotechnology
Antiva Biosciences, situated in South San Francisco, specializes in creating innovative, targeted medical…
Series E ·
$53M
V
Cambridge, United States · Biotechnology
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious…
Series E ·
$107M
C
Irvine, United States · Biotechnology
A privately held oncolytic immunotherapy firm called CG Oncology is dedicated to creating bladder-saving…
Series E ·
$120M
T
Westminster, United States · Biotechnology
The goal of TriSalus Life Sciences, an immunotherapy business, is to prolong and enhance the lives of people…
Series E ·
$24M
V
San Jose, United States · Biotechnology
VitalConnect creates wearable biosensors for wireless patient monitoring, utilizing their knowledge in…
Series E ·
$39M
V
Atlanta, United States · Biotechnology
Vero Biotech is a biopharmaceutical company focused on the design, development, and commercialization of…
Series E ·
$100M
R
Burlington, United States · Biotechnology
RedShiftBio provides an infrared technology with advanced data analytics to facilitate better, faster…
Series E ·
$20M
E
Austin, United States · Biotechnology
Elligo Health Research is a healthcare company that revolutionizes the clinical research industry with a…
Series E ·
$135M
E
Boston, United States · Biotechnology
Emulate is a privately held company that creates advanced in vitro models for understanding how diseases,…
Series E ·
$82M
B
San Francisco, United States · Biotechnology
Benchling is the modern software platform purpose-built for life science R&D. Hundreds of thousands of…
Series E ·
$200M
I
Boulder, United States · Biotechnology
With the first benchtop system for genome editing, Inscripta, a life science technology business, enables…
Series E ·
$150M

Where are funded Series E Biotechnology startups located?

Where funded Series E Biotechnology startups are based, by the city on the company record.

About the FundedIQ Series E Biotechnology startup funding data

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 26 funded Series E Biotechnology startups currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (1 of 8 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Series E Biotechnology startups is dated Aug 2026.

The table above shows the 26 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Series E Biotechnology startups are there?

FundedIQ tracks 26 funded Series E Biotechnology startups. This page lists the 26 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Series E Biotechnology startups raised?

Series E Biotechnology startups tracked by FundedIQ have raised $527M in disclosed capital across 8 funding rounds over the last 24 months, including 4 rounds in the last 12 months. 7 of those 8 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

Which cities have the most funded Series E Biotechnology startups?

Berkeley leads with 2 companies, then Boston (2), Cambridge (2) and Lexington (2).

What is a typical funding round size for Series E Biotechnology startups?

The median disclosed round over the last 24 months is $57M, and the middle half of rounds fall between $41M and $80M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

How often is the Series E Biotechnology startup funding data updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Series E Biotechnology startups is dated Aug 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.